[1] |
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA,2013,310(9):948-959.
|
[2] |
Ockrim Z, Yorston D. Managing diabetic retinopathy[J]. BMJ,2010,341:c5400.
|
[3] |
Wang Y, Vom Hagen F, Pfister F, et al. Receptor for advanced glycation end product expression in experimental diabetic retinopathy[J]. Ann N Y Acad Sci,2008,1126(1):42-45.
|
[4] |
Hudson BI, Stickland MH, Futers TS, et al. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy[J]. Diabetes,2001, 50(6):1505-1511.
|
[5] |
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med,1998,15(7):539-553.
|
[6] |
Ng ZX, Kuppusamy UR,Tajunisah I, et al. Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy[J]. Diabetes Res Clin Pract,2012,95(3):372-377.
|
[7] |
Klein R, Klein BE, Moss SE, et al. The wisconsin epidemiological study of diabetic retinopathy.Ⅱ.Prevalence and risk of diabetic retinopathy when age at diagnosis inless than 30 years[J].Arch Ophthalmol,1984,102(4):520-526.
|
[8] |
Salman AG, Mansour DE, Swelem AH, et al. Pentosidine-a new biochemical marker in diabetic retinopathy[J].Ophthalmic Res,2009,42(2):96-98.
|
[9] |
Münch G, Schinzel R, Loske C, et al. Alzheimer′s disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation end products[J]. J Neural Transm,1998, 105(4-5):439-461.
|
[10] |
Barile GR, Pachydaki SI, Tari SR, et al. The RAGE axis in early diabetic retinopathy[J]. Invest Ophthalmol Vis Sci,2005, 46(8):2916-2924.
|
[11] |
Schmdit AM, Yan SD, Yan SF, et al. The biology of the receptor for advanced glycation end products and its ligands[J].Biochem Biophys Acta,2000,1498(2-3):99-111.
|
[12] |
Kaji Y, Usui T, lshida S, et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a solubIe form of a receptor for advanced glycation end products[J]. Invest Ophthalmol Vis Sci,2007,48(2):858-865.
|
[13] |
Prasad P, Tiwari AK, Kumar KM, et al. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes[J]. BMC Med Genet,2010,11(1):52.
|
[14] |
Tripathi AK, Chawla D, Bansal S, et al. Association of RAGE gene polymorphism with vascular complications in Indian type 2 diabetes mellitus patients[J]. Diabetes Res Clin Pract,2014, 103(3):474-481.
|
[15] |
Yang L, Wu Q, Li Y, et al. Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in Chinese population[J]. J Diabetes Res,2013,2013:264579.
|
[16] |
Globocnik Petrovic M, Steblovnik K, Peterlin B, et al. The -429T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes[J]. Klin Monatsbl Augenheilkd,2003,220(12):873-876.
|
[17] |
徐积兄,徐碧林,杨明功,等. RAGE基因启动区-429T/C多态与2型糖尿病肾病相关[J]. 中华内分泌代谢杂志,2004,20(6):534-535.
|
[18] |
Kirbis J, Milutinovi A, Steblovnik K, et al. The -429T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes[J]. Coll Antropol,2004,28(2):611-616.
|
[19] |
Poon PY, Szeto CC, Chow KM, et al. Relation between polymorphisms of receptor for advanced glycation end products (RAGE) and cardiovascular diseases in Chinese patients with diabetic nephropathy[J]. Clin Nephrol,2010,73(1):44-50.
|
[20] |
Peng WH, Lu L, Wang LJ, et al. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus[J]. Arch Med Res,2009,40(5):393-398.
|